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ABSTRACT 
Motorneuronal diseases are fatal neurodegenerative diseases which include spinobulbar muscular 
atrophy (SBMA). Recent studies have demonstrated that both motorneuron and muscle cells are 
directly affected in SBMA patients. SBMA is caused by a poliglutammine stretch in the N-terminal 
region of the androgen receptor (AR) protein. In presence of testosterone ARpolyQ lose the proper 
conformation, misfolds and becomes toxic to cells. The protein quality control (PQC) system is in 
charge of protein homeostasis. The chaperone system maintains proteins in the proper conformation; if 
it fails misfolded proteins are directed to the degradative systems: the ubiquitin proteasome system 
(UPS) and the autophagy. We have already demonstrated that autophagy stimulation reduces protein 
aggregation in motorneuronal models of SBMA. Here we studied the involvement of the PQC system 
in the muscular response to misfolded toxic proteins and in the removal of aggregates, hallmark of the 
disease. 
We tried to potentiate the autophagic response with trehalose in muscle C2C12 cells stably expressing 
AR with a stretch of 100 glutamine (C2C12_ARQ100). By filter retardation assay (FRA) we observed 
that ARpolyQ aggregation was reverted by trehalose. By RTq-PCR analysis we found that trehalose 
increased the expression of the small heat shock protein B8 a molecular chaperone involved in the 
autophagic machinery. 
Overexpression of HspB8 in C2C12_ARQ100, interestingly, caused a significative reduction of 
ARpolyQ aggregation in FRA. 
We extend our findings to a SBMA-related motorneuronal disease: the amyotrophic lateral sclerosis 
(ALS). As model of sporadic ALS we studied the TAR-DNA-Binding Protein of 43 kDa (TDP43) and 
its truncated form TDP43-25 that aggregates in the cytoplasm. Trehalose treatment of muscle C2C12 
cells expressing both TDP43 and TDP43-25 caused no aggregate reduction. 
In conclusion we demonstrate that the enhancement of autophagy is a possible therapeutical strategy 
for treating SBMA; in the case of sporadic ALS other degradative pathways should to be investigated 
as autophagic facilitation can not prevent aggregate formation. 
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